🟢 Zevra Therapeutics is trading 5.1% up in pre-market with no verified company-specific catalyst identified

Zevra Therapeutics is trading 5.1% up at $12.44, with no verified company-specific catalyst identified for September 18, 2026.

• Recent coverage centers on September 15 healthcare-conference commentary.
• The investor-relations page shows no newer release than its September 2 conference announcement.
• Broader markets are only modestly higher, so the move’s cause remains unclear.